Gritstone bio Inc. (NASDAQ: GRTS)
$0.71
+0.0559 ( +8.50% ) 1.9M
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.
Market Data
Open
$0.71
Previous close
$0.66
Volume
1.9M
Market cap
$77.45M
Day range
$0.63 - $0.73
52 week range
$0.52 - $3.33
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | May 17, 2024 |
| 4 | Insider transactions | 1 | May 17, 2024 |
| 4 | Insider transactions | 1 | May 17, 2024 |
| 4 | Insider transactions | 1 | May 17, 2024 |
| 4 | Insider transactions | 1 | May 17, 2024 |
| 10-q | Quarterly Reports | 80 | May 09, 2024 |
| 8-k | 8K-related | 12 | May 09, 2024 |
| 4 | Insider transactions | 1 | Apr 30, 2024 |
| 3 | Insider transactions | 2 | Apr 30, 2024 |
| def | Proxies and info statements | 7 | Apr 29, 2024 |